Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”

  • 7 Accesses

  • 1 Citations

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Bahat G, Ilhan B, Karan MA. Comment on “Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide”. Drugs Aging. 2020. https://doi.org/10.1007/s40266-020-00751-4.

  2. 2.

    Raterman HG, Lems WF. Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide. Drugs Aging. 2019;36(12):1061–72. https://doi.org/10.1007/s40266-019-00714-4.

  3. 3.

    Buckley L, Humphrey MB. Glucocorticoid-Induced Osteoporosis. N Engl J Med. 2018;379(26):2547–56. https://doi.org/10.1056/NEJMcp1800214.

Download references

Author information

Correspondence to Hennie G. Raterman.

Ethics declarations

Funding

No funding was received for the preparation of this letter.

Conflicts of interest

Hennie G. Raterman has received an unrestricted educational grant from UCB, and consulting fees from Amgen, Cellgene and Sanof Genzyme. Willem F. Lems has received a grant from Pfzer, and consulting fees from MSD, Amgen, Lilly, Pfzer and UCB.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Raterman, H.G., Lems, W.F. Authors’ Reply to Comment on “Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide”. Drugs Aging (2020). https://doi.org/10.1007/s40266-020-00751-4

Download citation